CONFIPEN Trademark

Trademark Overview

On Monday, July 15, 2024, a trademark application was filed for CONFIPEN with the United States Patent and Trademark Office. The USPTO has given the CONFIPEN trademark a serial number of 98649565. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Wednesday, October 29, 2025. This trademark is owned by Amgen Inc.. The CONFIPEN trademark is filed in the Pharmaceutical Products category with the following description:

Injectors for medical purposes pre-filled with pharmaceutical preparations for treating cancer, immune, cardiovascular, metabolic and inflammatory diseases and conditions
confipen

General Information

Serial Number98649565
Word MarkCONFIPEN
Filing DateMonday, July 15, 2024
Status730 - FIRST EXTENSION - GRANTED
Status DateWednesday, October 29, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 1, 2025

Trademark Statements

Goods and ServicesInjectors for medical purposes pre-filled with pharmaceutical preparations for treating cancer, immune, cardiovascular, metabolic and inflammatory diseases and conditions

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 15, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAmgen Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 91320-1799
Party NameAmgen Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 91320-1799

Trademark Events

Event DateEvent Description
Monday, July 15, 2024NEW APPLICATION ENTERED
Monday, July 15, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, August 7, 2024TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, August 7, 2024TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Friday, September 6, 2024ASSIGNED TO EXAMINER
Monday, September 9, 2024NON-FINAL ACTION WRITTEN
Monday, September 9, 2024NON-FINAL ACTION E-MAILED
Monday, September 9, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 17, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, September 17, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, March 5, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 5, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 5, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 10, 2025EXAMINERS AMENDMENT -WRITTEN
Monday, March 10, 2025EXAMINERS AMENDMENT E-MAILED
Monday, March 10, 2025NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, March 10, 2025EXAMINER'S AMENDMENT ENTERED
Monday, March 10, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 26, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 1, 2025PUBLISHED FOR OPPOSITION
Tuesday, April 1, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 27, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 28, 2025SOU TEAS EXTENSION RECEIVED
Tuesday, October 28, 2025SOU EXTENSION 1 FILED
Wednesday, October 29, 2025SOU EXTENSION 1 GRANTED
Wednesday, October 29, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

confipen cardiovascular immune metabolic inflammatory conditions diseases cancer treating purposes medical